Professor | Xiao Zhang | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Xiao Zhang

Language ability

English, Chinese

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing Medical University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2011/09 - Present: Lecturer/Associate Professor at Nanjing Medical University, School of Basic Medical Sciences 2015/04 - 2016/04: Visiting Scholar at Harvard University, Massachusetts General Hospital 2008/09 - 2011/07: PhD at Nanjing Medical University, School of Basic Medical Sciences 2004/09 - 2007/07: Master's at Nanjing Normal University, School of Life Sciences 2000/09 - 2004/07: Bachelor's at Shanxi Normal University, School of Life Sciences Hosted 2 National Natural Science Foundation projects, 1 Jiangsu Science and Technology Department project, 1 Jiangsu Education Department project Received 5 national invention patents
Work Experience	2011/09 - Present: Lecturer/Associate Professor at Nanjing Medical University, School of Basic Medical Sciences 2015/04 - 2016/04: Visiting Scholar at Harvard University, Massachusetts General Hospital
Awards	2021: First Prize, 17th Jiangsu 'Challenge Cup' University Student Extracurricular Academic Science and Technology Works Competition, as a guiding teacher

University/Lab Affiliation and Title

Nanjing Medical University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2011/09 - Present: Lecturer/Associate Professor at Nanjing Medical University, School of Basic Medical Sciences
2015/04 - 2016/04: Visiting Scholar at Harvard University, Massachusetts General Hospital
2008/09 - 2011/07: PhD at Nanjing Medical University, School of Basic Medical Sciences
2004/09 - 2007/07: Master's at Nanjing Normal University, School of Life Sciences
2000/09 - 2004/07: Bachelor's at Shanxi Normal University, School of Life Sciences
Hosted 2 National Natural Science Foundation projects, 1 Jiangsu Science and Technology Department project, 1 Jiangsu Education Department project
Received 5 national invention patents

Work Experience

2011/09 - Present: Lecturer/Associate Professor at Nanjing Medical University, School of Basic Medical Sciences
2015/04 - 2016/04: Visiting Scholar at Harvard University, Massachusetts General Hospital

Awards

2021: First Prize, 17th Jiangsu 'Challenge Cup' University Student Extracurricular Academic Science and Technology Works Competition, as a guiding teacher

Areas of Focus	Development of fully human antibody drugs Tumor pathology mechanisms and tumor immunotherapy
Publications	Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram., Zhang X, Hu P, Ding SY, Sun T, Liu L, Han S, DeLeo AB, Sadagopan A, Guo W, Wang X., 2019 A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram., Juan Cong, Yangyang Wang, Xiao Zhang, Nan Zhang, Ling Liu, Klara Soukup, Theodoros Michelakos, Theodore Hong, Albert DeLeo, Lei Cai, Francesco Sabbatino, Soldano Ferrone, Hang Lee, Vera Levina, Bryan Fuchs, Kenneth Tanabe, Keith Lillemoe, Cristina Ferrone, Xinhui Wang., 2017 Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancreatic cancer cells., Yao Z, Li X, Gao J, Wang Y, Xiao L, Chang X, Liu F, Feng Z, Zhang X., 2022 Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades., Xiao Zhang, Xian Qi, Qianqian Zhang, Xiaoyan Zeng, Zhenqing Feng, Yongjun Jiao et al., 2013 The protective effect of a combination of human intracellular and extracellular antibodies against the highly pathogenic avian influenza H5N1 virus., Qiu Jin, Zhangyu Yao, Fangzhou Liu, Yaxuan Di, Jun Gao, Xiao Zhang., 2022

Areas of Focus

Development of fully human antibody drugs
Tumor pathology mechanisms and tumor immunotherapy

Publications

Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram., Zhang X, Hu P, Ding SY, Sun T, Liu L, Han S, DeLeo AB, Sadagopan A, Guo W, Wang X., 2019
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram., Juan Cong, Yangyang Wang, Xiao Zhang, Nan Zhang, Ling Liu, Klara Soukup, Theodoros Michelakos, Theodore Hong, Albert DeLeo, Lei Cai, Francesco Sabbatino, Soldano Ferrone, Hang Lee, Vera Levina, Bryan Fuchs, Kenneth Tanabe, Keith Lillemoe, Cristina Ferrone, Xinhui Wang., 2017
Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancreatic cancer cells., Yao Z, Li X, Gao J, Wang Y, Xiao L, Chang X, Liu F, Feng Z, Zhang X., 2022
Human 4F5 single-chain Fv antibody recognizing a conserved HA1 epitope has broad neutralizing potency against H5N1 influenza A viruses of different clades., Xiao Zhang, Xian Qi, Qianqian Zhang, Xiaoyan Zeng, Zhenqing Feng, Yongjun Jiao et al., 2013
The protective effect of a combination of human intracellular and extracellular antibodies against the highly pathogenic avian influenza H5N1 virus., Qiu Jin, Zhangyu Yao, Fangzhou Liu, Yaxuan Di, Jun Gao, Xiao Zhang., 2022

Antibody Drug Development Human Immunotherapy Tumor Pathology Mechanism Cancer Therapy Research

Kong Wei - Peking University

Yang Li - Peking University

Xiaowei Zhang - Peking University

View All

Personal Information